Pharma Manufacture
Private Label Sports Nutrition Manufacturing
Private Label Contract Manufacturing
About Pharma Manufacture
About
PHARMA MANUFACTURE is a contract development and manufacturing organization (CDMO) headquartered in Somerset, NJ.
It provides extensive capabilities across oral dose forms, biologics and cell therapy, and other dosage forms and services, serving global markets.
Categories & manufacturing capabilities
- Oral dose forms: large-scale manufacturing of tablets, capsules, and powders; includes pilot to GMP commercial scale operations.
- Biologics and cell therapy: CGMP manufacturing for cell therapies, including development, clinical, and commercial operations; includes gene therapy aspects and various cell types.
- Other dosage forms and services: oral, sterile, inhaled products; lipid-based delivery, particle size reduction, spray drying, and hot melt extrusion; includes complex supply and packaging capabilities.
- Global scale and throughput: multi-continental manufacturing network with extensive production volumes and clinical to commercial capabilities.
- Quality & compliance: FDA- and EMA-compliant CGMP manufacturing.
Production & operational capabilities
- Manufacturing scope: development, clinical, and commercial operations across multiple modalities.
- Facility scope: multiple sites with capabilities for large-scale production and specialized therapies.
- Technology transfer: supports technology transfer from clinical phases to commercial manufacturing.
Quality, compliance & regulatory positioning
- Certifications: FDA- and EMA-compliant CGMP facilities; accredited by 30+ global agencies.
What Pharma Manufacture manufactures
- Tablets
- Capsules
- Powders
- Cell therapies
- Biosimilars (mAbs)
- Fill-finish in vials and syringes
- Inhaled and sterile products
Frequently asked
We manufacture oral dose forms including tablets, capsules, and powders, and we also supply biologics, cell therapies, and other dosage forms such as lipid-based delivery and inhaled products.
Yes. We are a global CDMO providing development, clinical, and commercial manufacturing capabilities.
We offer CGMP manufacturing for cell therapies in FDA- and EMA-compliant facilities in Belgium and the USA, covering development, clinical, and commercial operations for allogeneic and autologous therapies, including gene therapy viral vector production and fill-finish.
Yes. We handle biosimilar development and manufacturing from cell line development to finished product, using GPEx technology, with multiple biosimilars manufactured in-house.
We provide fill-finish in vials, pre-filled syringes, and cartridges, along with clinical packaging, warehousing, and global distribution.
Our network of 30+ facilities on 5 continents produces 70+ billion doses annually and serves 80+ countries; the Winchester, KY site alone produces over 3 billion units annually.
Facilities are FDA- and EMA-compliant for CGMP manufacturing and are accredited by 30+ global regulatory agencies.